Bowlyn builds AI-powered playbooks and tools that help emerging biotech teams go from protocol to first patient enrolled — without reinventing the wheel.
Every new study means rebuilding SOPs, trackers, and workflows from scratch. Your team spends more time on process than on the trial itself.
No infrastructure to guide decisions. Endless pivots, tight budgets, and a team of three doing the work of thirty with no institutional knowledge to fall back on.
Veeva costs $200K+. IQVIA is built for big pharma. The tools that exist weren’t designed for you — and nobody is building for you either.
Protocol not final? No sweat. Start with a concept, synopsis, or full draft. Share whatever you know — phase, indication, countries, outsourced model. The more context, the more tailored the output.
Receive customized SOPs, study startup plans, vendor oversight frameworks, risk registers, and operational playbooks — in hours, not weeks.
Hit the ground running with operational infrastructure that would normally take months to build. Your team executes instead of reinventing.
Your complete study startup infrastructure — built in hours, not weeks. Upload your protocol or synopsis and receive customized SOPs, site selection frameworks, vendor oversight tools, and communication templates tailored to your trial. Optional protocol development support includes CtQ design review, feasibility assessment, and ICH E6(R3) compliance alignment. Powered by Bowlyn Navigator. FPIQ™: First Patient In — Qualified, Quickly, with Quality.
Your dedicated VP of Clinical Operations — accessible through a private client portal and by email, with answers within 24 hours. Onboard your program once; ask anything from CRO governance to site activation timelines. Every response is reviewed by a real clinical ops expert before it reaches you. Not a chatbot. A real person, every time.
Upload your protocol, get customized SOPs, checklists, and timelines — not boilerplate templates from a generic AI.
All AI runs through enterprise API infrastructure where your data is contractually never used for model training. Encrypted at rest and in transit, with tenant isolation between customers. Your protocol data stays yours.
Learns from patterns across dozens of biotech teams — what works, what fails, and the common mistakes at each stage.
Running Phase 1–3 trials with lean teams, tight budgets, and no inherited infrastructure or institutional playbook.
You’re the first (or only) ops hire. Every SOP, tracker, and workflow has to be created before the trial can move forward.
You outsourced the trial but not the accountability. You need governance frameworks, KPIs, and oversight plans — yesterday.
The timeline was set before ops was consulted. Now you need infrastructure that compresses months of setup into weeks.
You serve multiple clients, each with their own protocol and complexity. Bowlyn gives you expert infrastructure on demand — so you deliver faster and with more depth.
You're driving the science and the strategy — but the operational infrastructure isn't keeping pace. You need a partner who can translate your development plan into trial-ready execution.
“Trials don’t fail because the science was wrong. They fail when protocols can’t be executed, vendors work in silos, and operational plans are reactive instead of proactive.”
— The founding principle behind Bowlyn
Our team brings global clinical operations experience, end-to-end trial management expertise, and a track record of successful approvals — across therapeutic areas and development phases, at emerging biotechs, CROs, and large pharma.